首页|青斑样血管病抗炎治疗进展

青斑样血管病抗炎治疗进展

扫码查看
青斑样血管病是一种难治性皮肤血管病,通常发生于下肢足踝部位,早期表现为网状青斑和疼痛性溃疡,后期形成白色萎缩,皮疹常反复发作.青斑样血管病的典型组织病理表现为真皮内血管纤维素沉积和血栓形成.目前的主流观点认为青斑样血管病是血栓性疾病,治疗以抗凝为主.然而临床上有部分患者抗凝治疗效果欠佳,且常出现复发.近期研究发现,部分青斑样血管病存在淋巴细胞性血管炎,提示本病存在炎症病理基础.抗炎治疗也是临床上治疗本病的常用方案.该文简要综述了青斑样血管病的抗炎治疗进展.
Progress in anti-inflammatory therapy of livedoid vasculopathy
Livedoid vasculopathy is a refractory cutaneous vascular disease.Clinically,it usually occurs in the ankle and lower extremities,with early manifestations of livedoid reticular and painful ulcers,followed by white atrophic scars in later stages.Typical histopathological manifestations of livedoid vasculopathy are occlusion of vessels in the dermis by fibrin deposition and intravascular thrombosis.Currently,the mainstream view is that livedoid vasculopathy is a thrombotic disease,anticoagulation is most commonly used.However,some patients with relapsed illness showed poor response to anticoagulation.In recent study,we found that lymphocytic vasculitis was present in some patients,suggesting that there is an inflammatory pathology underlying the disease.Anti-inflammatory therapy is also a common option for this disease.In this article,we briefly review the progress in anti-inflammatory treatment of livedoid vasculopathy.

Livedoid vasculopathyLymphocytic vasculitisAnti-inflammatory therapyJAK inhibitorsTNF-α inhibitorsReview

班发展、廖文俊、王雷

展开 >

710032 西安,空军军医大学西京医院皮肤科,西京皮肤医院

青斑样血管病 淋巴细胞性血管炎 抗炎治疗 Janus激酶抑制剂 肿瘤坏死因子α抑制剂 综述

2024

实用皮肤病学杂志
中国人民解放军北京军区总医院

实用皮肤病学杂志

CSTPCD
影响因子:0.637
ISSN:1674-1293
年,卷(期):2024.17(6)